We are live on ! Find out more
NGNE icon

Neurogene
NGNE

52 hedge funds and large institutions have $253M invested in Neurogene in 2017 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 6

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

64% more call options, than puts

Call options by funds: $208K | Put options by funds: $127K

21% more funds holding

Funds holding: 43 → 52 (+9)

0.07% more ownership

Funds ownership: 4.51% → 4.58% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16% less capital invested

Capital invested by funds: $300M → $253M (-$47.5M)

Holders
52
Holders Change
+9
Holders Change %
+20.93%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
16
Reduced
9
Closed
6
Calls
$208K
Puts
$127K
Net Calls
+$81K
Net Calls Change
+$477K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.81M
2
Millennium Management
Millennium Management
New York
+$1.37M
3
UONDDL
University of Notre Dame du Lac
Indiana
+$712K
4
EU
Emory University
Georgia
+$552K
5
SCM
Stonepine Capital Management
Oregon
+$474K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.19M
2
Goldman Sachs
Goldman Sachs
New York
-$1.78M
3
VEA
Virtus ETF Advisers
New York
-$339K
4
AP
Archon Partners
New Jersey
-$268K
5
ProShare Advisors
ProShare Advisors
Maryland
-$188K
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$129M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$39.7M -$5.86K -25 -0%
Franklin Resources
3
Franklin Resources
California
$15.7M +$168K +718 +1%
BlackRock
4
BlackRock
New York
$11.9M -$4.19M -17,880 -26%
Goldman Sachs
5
Goldman Sachs
New York
$9.54M -$1.78M -7,588 -16%
GTC
6
Ghost Tree Capital
New York
$4.7M – – –
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$3.82M +$3.81M +16,255 New
BC
8
Boxer Capital
California
$3.67M – – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$3.5M +$24.1K +103 +0.7%
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$3.32M – – –
UONDDL
11
University of Notre Dame du Lac
Indiana
$2.95M +$712K +3,041 +32%
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$2.94M – – –
AC
13
Ascend Capital
California
$2.54M +$19.9K +85 +0.8%
EAM
14
Eventide Asset Management
Massachusetts
$2.06M – – –
EU
15
Emory University
Georgia
$2M +$552K +2,357 +38%
RA
16
Royce & Associates
New York
$1.71M – – –
Millennium Management
17
Millennium Management
New York
$1.62M +$1.37M +5,842 +549%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$1.42M -$13.4K -57 -0.9%
DCM
19
DAFNA Capital Management
California
$1.4M +$461K +1,969 +50%
Northern Trust
20
Northern Trust
Illinois
$998K -$4.92K -21 -0.5%
TD Asset Management
21
TD Asset Management
Ontario, Canada
$995K – – –
SFM
22
Sphera Funds Management
Israel
$888K – – –
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$668K – – –
BCM
24
Bridgeway Capital Management
Texas
$588K – – –
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$490K +$341K +1,454 +231%
1
2 3

NGNE Hedge Fund Activity: Q4 2017 in Review

52 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q4 2017, worth a combined $253M — down 16% from $300M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new NGNE positions and 6 closed out — a net gain of 9 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $3.81M. The largest seller was BlackRock, cutting an estimated $4.19M.

  • 52 institutional investors held Neurogene (NGNE) as of Q4 2017, up from 43 in Q3 2017.
  • Funds reported $253M of Neurogene stock for Q4 2017, down 16% quarter-over-quarter.
  • 15 funds opened new Neurogene positions in Q4 2017 and 6 closed out, a net change of +9 holders.
  • The largest Neurogene buyer in Q4 2017 was Point72 Asset Management, an estimated $3.81M added.
  • The largest Neurogene seller in Q4 2017 was BlackRock, an estimated $4.19M sold.

Based on aggregated 13F filings for Q4 2017.